Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update

Avalon GloboCare Corp. (NASDAQ:ALBT) was the target of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 9,900 shares, an increase of 37.5% from the January 31st total of 7,200 shares. Currently, 2.3% of the shares of the company are short sold. Based on an average daily trading volume, of 837,800 shares, the days-to-cover ratio is currently 0.0 days.

Avalon GloboCare Stock Performance

ALBT opened at $9.01 on Tuesday. The company’s 50-day simple moving average is $4.09 and its two-hundred day simple moving average is $3.69. The stock has a market capitalization of $9.86 million, a P/E ratio of -0.45 and a beta of 0.19. Avalon GloboCare has a 52-week low of $2.11 and a 52-week high of $21.60.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.